Who Paid My Doc
A Phase 3 Multinational Doubleblind Randomized Placebocontrolled Study of Mgl3196 Resmetirom in Patients With Nonalcoholic Steatohepatitis Nash and Fibrosis to Resolve Nash and Reduce Progression to Cirrhosis Andor Hepatic Decompensation
ClinicalTrials.gov NCT03900429
Research payments
$10,941,632
Through program year 2025, $10,941,632 in research payments was reported against A Phase 3 Multinational Doubleblind Randomized Placebocontrolled Study of Mgl3196 Resmetirom in Patients With Nonalcoholic Steatohepatitis Nash and Fibrosis to Resolve Nash and Reduce Progression to Cirrhosis Andor Hepatic Decompensation, across 1,878 payments, paid by Madrigal Pharmaceuticals.
- Paid by
- Madrigal Pharmaceuticals
- ClinicalTrials.gov
- NCT03900429
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $8,083,797 | 1,436 |
| 2024 | Research | $2,857,835 | 442 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Guy Neff Sarasota, FL Named on 210 payments
- Madhavi Rudraraju San Antonio, TX Named on 83 payments
- Mangesh Pagadala Dallas, TX Named on 80 payments
- Anita Kohli Chandler, AZ Named on 77 payments
- Rashmee Patil McAllen, TX Named on 77 payments
- Rohit Puskoor Fort Worth, TX Named on 66 payments
- Manuel Rodriguez Bradenton, FL Named on 65 payments
- Sridhar Guduri Dublin, OH Named on 49 payments
- Cynthia Moylan Durham, NC Named on 43 payments
- Daniel Santillano San Antonio, TX Named on 40 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.